SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), in response to investor inquiries, is confirming that it has no banking or other financial relationship with Silicon Valley Bank. Omeros previously maintained a line of credit with Silicon Valley Bank, which the company allowed to expire in August 2022. Omeros does not have any assets on deposit with Silicon … [Read more…]
NASHVILLE, Tenn.–(BUSINESS WIRE)–AMSURG, a division of Envision Healthcare and a national leader in outpatient care, is spreading awareness about colorectal cancer prevention and advocating for opportunities to improve screening rates and the health of communities across the country. As part of its efforts, AMSURG teams are engaging with legislators and industry leaders in Washington, D.C., … [Read more…]
AMSTERDAM–(BUSINESS WIRE)–#GreedyGilead–To continue pressuring pharmaceutical giant Gilead Sciences to stop its greedy tactics and put lives before profits, AIDS Healthcare Foundation Europe will hold a protest at Gilead offices in Amsterdam on March 14 at 12:00 p.m. Gilead is one of the worst offenders of big pharma profiteering, and at the same time, it has … [Read more…]
WASHINGTON–(BUSINESS WIRE)–#pathologists–College of American Pathologists (CAP) President Emily E. Volk, MD, FCAP met with the Congressional Black Caucus (CBC) Health Braintrust during a forum to discuss strategies to address inequities in health care on March 10. Dr. Volk provided an overview of the CAP’s work to eliminate disparities in diagnostic algorithms and reference ranges, as … [Read more…]
ACQUISITION ADDS PROMINENT TEXAS-BASED GROUP SPECTRUM THERAPY CONSULTANTS TO EMPOWER FAMILY PHOENIX–(BUSINESS WIRE)–Empower Physical Therapy today announced the acquisition of Spectrum Therapy Consultants (“STC”), located in El Paso, Texas. Founder-owner, Sandra Terrazas, PT, MBA is an El Paso native and established STC in 2006 to provide contract therapy services to the local community. STC became … [Read more…]
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval (PMA) application for Shield™, Guardant Health’s blood test to screen for colorectal cancer (CRC). The submission is comprised of data from … [Read more…]
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated end-to-end solution for digital pathology that brings together best-in-class products from Agilent, Visiopharm, Proscia®, and Hamamatsu Photonics K.K. The announcement coincides with the USCAP 112th Annual Meeting held March 11-16 at the New … [Read more…]
WESTON, Fla.–(BUSINESS WIRE)–ILiAD Biotechnologies, LLC (ILiAD), a vaccine company utilizing its B-Tech technology to develop novel vaccines against infectious diseases, today announced a peer-reviewed publication in The Lancet. The published research article summarizes the adult Phase 2b clinical study of BPZE1, the most advanced next generation pertussis vaccine. The multi-center, double-blinded, randomized trial was designed … [Read more…]
An end-to-end digital pathology solution now available SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution. With the addition of the … [Read more…]
– Three presentations, including two orals, will highlight the efficacy, tolerability and pharmacokinetics of VTAMA cream for the treatment of adults with plaque psoriasis LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that data from multiple studies of VTAMA® (tapinarof) cream, … [Read more…]
